Article
Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome
15 May 2020
Abstract excerpt
Efficacy of conventional chemoimmunotherapy is limited in patients with Richter syndrome (RS) with anticipated median overall survival (OS) of less than 10 months. Allogeneic hematopoietic cell transplantation (allo-HCT) is commonly offered as a consolidative treatment option in RS. To our knowledge, there are no randomized controlled studies that have compared allo-HCT against other therapies in RS; available...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
